Skip to main content
Erschienen in: BMC Gastroenterology 1/2022

Open Access 01.12.2022 | Research

Association between dietary antioxidant index and risk of Helicobacter pylori infection among adults: a case–control study

verfasst von: Zohreh Ebrahimi, Mohsen Masoodi, Zahra Aslani, Sina Naghshi, Masoumeh Khalighi Sikaroudi, Farzad Shidfar

Erschienen in: BMC Gastroenterology | Ausgabe 1/2022

Abstract

Backgrounds and aims

One of the most important risk factors for Helicobacter pylori (H. pylori) infection is nutrition. Balanced diets with high antioxidant properties may have protective effects against the consequences of this infection. In the current study, we aimed to investigate the association between the dietary antioxidant index and the risk of H. pylori infection among adults.

Methods

In a case–control study the dietary intake of patients with H. pylori infection was compared with healthy subjects. The dietary antioxidant index (DAI) was calculated using dietary intakes derived from a validated food frequency questionnaire (FFQ). Demographic information was obtained by a related questionnaire and Physical Activity was measured by International Physical Activity Questionnaire (IPAQ) were used to obtain information. Using logistic regression models, we evaluated the association between the DAI and H. pylori infection risk. The significance level was determined as P < 0.05.

Results

Finally, dietary data of 148 cases and 302 controls (mean age: 38.72 ± 10.61 (were analyzed. The mean of total DAI was significantly higher in controls (7.67) when compared with H. pylori cases (3.57) (P < 0.001). After adjustment for covariates, participants with less than median DAI values had an increased risk of H. pylori onset (adjusted OR 1.08, 95% CI: 1.02–1.12, P < 0.001).

Conclusions

Appropriate intake of nutrient antioxidants may have a role in decreasing the likelihood of H. pylori infection risk.
Hinweise

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
BMI
Body mass intake
CI
Confidence interval
DAI
Dietary antioxidant index
FFQ
Food frequency questionnaire
H. pylori
Helicobacter pylori
IPAQ
International Physical Activity Questionnaire
OR
Odds ratio
IARC
International Association for Cancer Research
IQR
Interquartile range
SD
Standard deviation

Introduction

Helicobacter pylori (H. pylori) is a gram-negative, microaerophilic and spiral shape pathogen, which replicates in the gastric epithelium layer and can be transferred directly (oral–oral) or indirectly (fecal–oral) to another. [1]. Approximately, there were 4.4 billion individuals with H. pylori infection worldwide [2]. In a study conducted in Jordan, Iran, Russia, China, Canada and Latin American countries, a large outbreak of H. pylori infection was reported [3]. This bacterium recognized to main factor of chronic gastritis, peptic ulcer and primary gastric lymphoma and according to the definition of the International Association for Cancer Research (IARC) type I carcinogenic agent [4]. The pathogenic effect of Helicobacter pylori infection is more in the upper gastrointestinal tract. Helicobacter pylori can indirectly affect the brain-gut axis in addition to its direct proinflammatory and cytotoxic effects [5].
Along other risk factors, nutrition and nutritional status play an important role in Helicobacter pylori infection. Therefore, a balanced diet, especially high consumption of fruits and vegetables, might protects people versus he consequences of H. pylori infection [6]. In a study that assessed the association of dietary patterns with H. pylori infection, high intake of grain and vegetables, was inversely related to Helicobacter pylori infection [7]. On the contrary, a diet full of carbohydrates and sweets was related to a higher H. pylori infection prevalence [8].
Enough intake of dietary antioxidants predominantly from fruits and vegetables can provide a balanced defense mechanism against the harmful effects of reactive oxygen species [9]. Bacterial growth is inhibited by antioxidants through reducing reactive oxygen species and inflammations caused by H. pylori [10]. Studies have indicated that H. pylori infection is related to the deficiencies in vitamin A, C, and E [1114]. Moreover, vitamins C and E has shown an inhibitory effect on H. pylori intensity and neutrophilic activity [15, 16]. The gastric epithelium damage which is caused by H. pylori has a direct relationship with reduced concentration of vitamin C [9]. Several studies have shown that concentration of vitamins C and E are lower in peoples with H. pylori than in those without H. pylori [1721].
The dietary antioxidant index (DAI) has become a valid indicator that considers total dietary antioxidant properties at once. As the importance of dietary antioxidants has been shown in the prevention and control of H. pylori infection, the total dietary antioxidant capacity can be evaluated by the DAI in these patients. Based on our knowledge the present study is the first study which was planned and conducted to investigate the relation to between DAI and H. pylori infection.

Materials and methods

Study design and participants

A total of 148 patients with H. pylori infection and 302 H. pylori negative subjects participated in the case–control study. The participants in the case group (H. pylori positive) were recruited from the Gastroenterology clinic, Rasoul-e-Akram Hospital, Tehran, Iran; between June 2021 and November 2021. These patients were newly diagnosed (active phase of the infection) with H. pylori and were not under treatment prior to participation in this study. For H. pylori infection diagnosis, we used one of the following methods: blood antibody, fecal antigen, urea breath test (UBT), endoscopy and gastric biopsy. The control group was twice as numerous as the case group and comprised patients referred to other sections of this hospital (ophthalmology, orthopedics, maxillofacial surgery, and otorhinolaryngology) which had no infection with H. pylori based on only one of the following diagnostic methods: blood antibody, fecal antigen, urea breath test (UBT), endoscopy and gastric biopsy. All the H. pylori negative subjects who entered the study were new cases. In addition, people who had Helicobacter before and were treated or who are resistant to treatment were not included in the control group and were excluded from the study. Participants who had a medical history of certain diseases (gastrointestinal cancers, psychosis or diseases that would result in memory disturbances), pregnancy, lactating and having an arbitrary special diet considered as an exclusion criteria. Also, individuals who over-or under-estimated their energy intake (> 4200 or < 800 kcal/d) were excluded [22]. Cases and controls were matched for age, sex, and smoking.

Anthropometric assessment

Anthropometric measurements were conducted by a trained dietician. Weight was measured with minimum clothing, without shoes, by using a digital scale (Seca 807, made in Germany) (100 g accuracy). Standing height measurement was done without shoes, flat feet against a wall, arms at sides, looking straight by a stadiometer (Seca 206) (0.5 cm accuracy). Body mass index (BMI) was calculated as weight (kg) divided by height in square meters (m2).

Assessment of other variables

Data on age, sex (male/female), smoking (yes/no), and alcohol consumption (yes/no) of the participants were collected through face-to-face interviews by related questionnaires. We used the International Physical Activity Questionnaire (IPAQ) to measure the current physical activity of participants through face-to-face interviews [23].

Dietary assessment and dietary antioxidant index (DAI)

Dietary intakes were assessed using a validated block-format 168-item food frequency questionnaire (FFQ) in the preceding year [24]. Two experienced interviewers fulfilled FFQ. Based on this questionnaire, participants were asked to report their dietary intakes in a format of day, week, month, or year. Moreover, they should report their intakes based on the serving size of each food item. To increase the accuracy of estimates, interviewers showed household measurements or serving size of each food item to participants. Finally, based on each item’s consumption frequency and serving size, we calculated the gr/day intake of each food item. In addition, we calculated the daily nutrients intake for each participant according to the nutrient contents of foods.
We also calculated DAI for the participants based on FFQ data. We utilized previously published databases from the USA and Italy, containing the most commonly consumed foods for calculation of DAI [25]. The validity of this index was measured before [26]. We used the method which recommended by Benzie for measuring the total antioxidant capacity of the participants’ food intake (their dietary antioxidant index) [27]. To obtain the DAI, we standardized each of vitamin A, C, E, selenium, manganese, and zinc by subtracting the value of global mean intake of each dietary antioxidant factor from reported consumed amount. Then, this number was divided by world standard deviation. Finally, the DAI was calculated by summing the standardized intakes, as described below.
$${\text{DAI}} = \mathop \sum \limits_{{{\text{i}} = 1}}^{n = 6} \frac{{{\text{Individual}}\;\;{\text{ intake }} - {\text{ Mean}}}}{SD}$$

Statistical analysis

Statistical analysis was conducted using Statistical Package Software for Social Science, version 21 (SPSS Inc., Chicago, IL, USA). The Kolmogorov–Smirnov’s test and histogram chart were used to test the normality of the data. Baseline characteristics and dietary intakes were expressed as mean ± SD or median (interquartile range (IQR)) for quantitative variables with normal and skewed distribution, respectively. Furthermore, the number (percentage) was used to indicate the qualitative variables. Comparison of the data between two groups was done using independent sample t-test and chi square for continuous and categorical variables, respectively. Binary logistic regression was used to estimate odds ratios (ORs) and 95% confidence intervals (CIs) adjusted for multiple covariates in different models. The significance level was determined as P < 0.05.

Result

Among 153 patients with H. pylori infection and 306 healthy subjects, finally, 148 case and 302 controls had completed information regarding dietary intakes and were included in the statistical analysis after excluding individuals who over-or under-estimated their energy intake. The mean age of study participants was 38.72 ± 10.61 years, and 59.8% were female. General characteristics of case and control groups are indicated in Table 1. Compared with those in the control groups, individuals with H. pylori infection were significantly older, had higher BMI and smoked more. No other significant difference was observed in. Other characteristics (Table 1).
Table 1
Baseline characteristics and hematological parameters of the study participant
Variables
Cases (148)
Controls (302)
P value
Age (years)
41 (32, 52.75)
36 (30, 43)
 < 0.001
BMI
27.01 (23.87, 31.22)
24.67(22.53, 26.87)
 < 0.001
Male, N(%)
46 (31.1)
135 (44.7)
0.004
Current smokers, N (%)
11 (7.4)
8 (2.6)
0.019
Alcohol consumption, N (%)
16 (10.8)
21 (7.0)
0.113
Physical activity, N (%)
Low
113 (76.3)
220 (72.8)
 < 0.001
Moderate
29 (19.6)
59 (19.5)
 
High
6 (4.1)
23 (7.6)
 
Data are presented as mean ± SD or percent (N)
BMI body mass index
Obtained from the analysis of independent-samples T Test or chi-squared test, where appropriate
As we show in Table 2, individuals with H. pylori had a lower intake of vitamin E, vitamin A, manganese, and selenium compared to controls. Other differences in dietary intakes among the cases and controls were not significant.
Table 2
Dietary intake among the case and control groups
Variables
Cases (148)
Controls (302)
P value
Vitamin E (mg/d)
10.48 (7.99,13.96)
12.46 (9.65, 15.45)
0.001
Vitamin A (RAE/d)
402.85(283.95, 568.83)
553 (370.29, 786)
 < 0.001
Vitamin C (mg/d)
132 (86.76, 169.38)
112 (75.76, 159.38)
0.334
Zinc (mg/d)
13.53 (10.88, 16.87)
10.49 (8.69, 12.83)
0.124
Manganese (mg/d)
6.32 (4.91,8.02)
10.20 (7.49,13.28)
 < 0.001
Selenium (mg/d)
103.44 (81.75, 129.88)
130.85 (98.97, 174.36)
 < 0.001
Data are presented as median (interquartile range )IQR()
Obtained from the analysis of 2-independent- samples Tests
The mean of total DAI was significantly higher in controls (7.67) when compared with H. pylori cases (3.57) (P < 0.001). The crude and adjusted ORs (95% CIs) for the underlying associations between both continuous and categorical DAI with H. pylori risk have been shown in Table 3. We observed a significant decrease in the H. pylori risk (OR 0.82, 95% CI: 0.75–0.89, P < 0.001) when continuous DAI was increased. Participants with less than median DAI values had increased risk of H. pylori onset (adjusted OR 1.08, 95% CI: 1.02–1.12, P < 0.001).
Table 3
Association between DAI and H. pylori risk
 
Case (148)
Control (302)
Unadjusted OR (95% CI)
P-value*
Adjusteda OR (95% CI)
P value
Total DAI, mean (SD)
3.57 (1.55)
7.67 (2.74)
0.87 (0.81, 0.92)
 < 0.001
0.82 (0.75, 0.89)
 < 0.001
  >  Median, N(%)
102 (22.7)
123 (27.3)
1
1
  ≤ Median, N(%)
46 (10.2)
179 (39.8)
1.07 (1.04, 1.10)
 < 0.001
1.08 (1.02, 1.12)
 < 0.001
Data are presented as OR (95% CI)
DAI Dietary antioxidant index
*P for trend: obtained from binary logistic regression
aAdjusted for age, sex, smoking, alcohol, physical activity, BMI, education and total energy

Discussion

In the current study, DAI as a continuous variable was inversely associated with H. pylori infection. We also found a significant positive association between lower DAI and odds of H. pylori infection in functional categories (≤ Median vs. > Median). H. pylori is one of the most common bacterial infections in human beings. The role of H. pylori infection in gastric cancers and other gastrointestinal tract diseases has been widely established [28]. Available evidence indicates that diet has important role in developing H. pylori infection. Therefore, protective dietary factors are important from a public health point of view. While some nutritional research has widely focused on single nutrients or foods in diet-disease relations, the overall diet could be more informative because humans typically consume a combination of nutrients and foods. Dietary indices such as DAI are one of the approaches for this purpose which considers the whole quality of the diet. A significant inverse association has been reported between DAI and some diseases with inflammatory nature, including gastric cancer [29], colorectal cancer [30], nonalcoholic fatty liver [31], and obesity [32]. To our knowledge, no previous studies have investigated DAI in relation to H. pylori infection. The results from this study are consistent with a cross-sectional study, which found healthy subjects significantly have higher intakes of fruits, vegetables, and vitamin C compared to subjects with H. pylori infection. However, no significant differences were observed in vitamin A and E and zinc intake [33]. In another study that examined the association of dietary factors with H pylori re-infection, high consumption of fruit and vegetables, which contains vitamin C, was associated with decreased risk of H pylori re-infection [34]. In a cross-sectional study on 1106 men and women, plasma vitamin C level for H. pylori-infected patients was only 80% of that for non-infected individuals [18]. Similar findings were also seen in the study of Annibal et al., in which plasma ascorbic acid concentrations were lower in H. pylori -infected groups than in healthy controls [35]. Finding from a small randomized clinical trial showed that Zinc L-carnosine supplements in combination with three medications (lansoprazole, amoxicillin, clarithromycin) could significantly improve the cure rate for H. pylori [36]. It has been shown that H. pylori-infected patients with non-atrophic chronic gastritis had lower zinc concentrations in gastric mucosa than uninfected patients with the same type of gastritis [37]. Our findings were also consistent in line with evidence from animal studies. For example, one study reported that high doses of vitamin C could inhibit the in vitro and in vivo colonization of H. pylori [38]. In an animal study, a high intake of selenium, β-Carotene, and vitamins A, C, and E in the Guinea Pig led to a significant reduction in H. pylori growth [39]. Two further animal studies reported that zinc supplementation inhibits H. pylori -induced gastric mucosal oxidative inflammation in gerbils [40, 41]. In contrast to our findings, two meta-analyses of randomized controlled trials reported that supplementation with vitamins C and/or E could not improve the eradication rate of H. pylori [42, 43]. The reason that high doses of vitamin C is not able to eradicate H. pylori infection might be explained by the fact that at chronic infection, some patients develop relative achlorhydria that leads to lower acidity of gastric juice [44]. In such conditions, the anti-urease role of vitamin C in eradicating H. pylori is relatively less important. Furthermore, the complex mixture of diet-deriving nutrients may be more effective than high doses of single micronutrient supplements. It is possible that such nutrients interact or work together but have smaller effects individually [45]. Moreover, this non-significant effect may be partly due to the small sample size, limited duration of intervention, and low to moderate methodological quality of some of the H. pylori RCTs. Therefore caution is needed in interpreting the results of such studies.
Several biologically plausible reasons may explain why dietary antioxidants might be, either directly or indirectly, a protective factor againstH.pylori infection. It is well-known that antioxidants, with their free radical scavenging activities, can inhibit the growth of H. pylori [39]. H. pylori is urease positive and can synthesize a large amount of urease for ammonia production to neutralize the gastric acid, allowing it to colonize in the stomach epithelium [46]. It has been shown that vitamin C inhibits urease activity [47]. Moreover, vitamin C improves the stimulation and activity of granulocytes, macrophages, lymphocytes, and immunoglobulin production [34, 48]. In vitro studies, showed that zinc inhibits the urease enzyme and prevents H.pylori adhesion to gastric mucin. Mucosal inflammation may be required for H. pylori infection to persist, and the anti-inflammatory effects of antioxidants could inhibit H. pylori growth [39, 49].

Strengths and limitations

This study included both strengths and weaknesses that should be noted. Our study is the first report to investigate the association of DAI and H. pylori infection; it has high scientific competence and novelty level. Moreover, results were significant in different statistical approaches (continuous and categorical). We also used valid and reliable questionnaires for data collection, which can further support the accuracy of findings. The nearly complete participation of identified cases and controls is another strength of our study. Limitations of the current study are generic concerns for case–control studies. The causality of the associations cannot be established from this study. Because we used FFQ for dietary assessment, inaccurate measures of dietary intakes may have resulted in misclassification. As participants reported past dietary habits, recall bias may have occurred, particularly among patients, as changes in lifestyle may occur when H. pylori infection develops and becomes symptomatic. Nevertheless, we included newly diagnosed patients who were interviewed by uniformly trained interviewers in their hospital settings and were unaware of any study hypothesis to minimize changes in dietary habits. It is possible that selection bias may have resulted from using hospital-based controls since these controls include individuals with conditions that could potentially be related to their dietary antioxidants intake. Moreover, the significant association between DAI and H. pylori infection could be due to unmeasured or residual confounding. Finally, we did not have data on cooking methods of antioxidant-rich foods that could alter the antioxidant content of such foods.

Conclusion

This case–control study provides evidence for an inverse association between higher DAI and odds of H. pylori infection. More in-depth studies are needed to confirm our findings.

Acknowledgements

We would wish to thank the patients who graciously agreed to participate in this research.

Declarations

The study was conducted after approval by the Research Ethics Committee of Iran University of Medical Sciences (IR.IUMS.REC 1396.32632). We confirm that all methods were performed in accordance with the relevant guidelines and was approved by the institution, either. The aim of the study was completely stated to the participants and written informed consent were signed by all participants.
Not applicable.

Competing interests

The authors declared that there were no conflicts of interest.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat Alipour M. Molecular mechanism of Helicobacter pylori-induced gastric cancer. J Gastrointest Cancer. 2021;52(1):23–30.PubMedCrossRef Alipour M. Molecular mechanism of Helicobacter pylori-induced gastric cancer. J Gastrointest Cancer. 2021;52(1):23–30.PubMedCrossRef
2.
Zurück zum Zitat Hooi JK, Lai WY, Ng WK, Suen MM, Underwood FE, Tanyingoh D, Malfertheiner P, Graham DY, Wong VW, Wu JC. Global prevalence of Helicobacter pylori infection: systematic review and meta-analysis. Gastroenterology. 2017;153(2):420–9.CrossRefPubMed Hooi JK, Lai WY, Ng WK, Suen MM, Underwood FE, Tanyingoh D, Malfertheiner P, Graham DY, Wong VW, Wu JC. Global prevalence of Helicobacter pylori infection: systematic review and meta-analysis. Gastroenterology. 2017;153(2):420–9.CrossRefPubMed
3.
Zurück zum Zitat Mezmale L, Coelho LG, Bordin D, Leja M. Epidemiology of Helicobacter pylori. Helicobacter. 2020;25: e12734.PubMedCrossRef Mezmale L, Coelho LG, Bordin D, Leja M. Epidemiology of Helicobacter pylori. Helicobacter. 2020;25: e12734.PubMedCrossRef
4.
Zurück zum Zitat Bardazzi F, Magnano M, Fiorini G, Vaira D, Odorici G, Bertusi G, Patrizi A, Helicobacter Pylori infection in psoriatic patients during biological therapy. Giornale Italiano di Dermatologia e Venereologia: Organo Ufficiale, Societa Italiana di Dermatologia e Sifilografia 2020. Bardazzi F, Magnano M, Fiorini G, Vaira D, Odorici G, Bertusi G, Patrizi A, Helicobacter Pylori infection in psoriatic patients during biological therapy. Giornale Italiano di Dermatologia e Venereologia: Organo Ufficiale, Societa Italiana di Dermatologia e Sifilografia 2020.
5.
6.
Zurück zum Zitat Öztekin M, Yılmaz B, Ağagündüz D, Capasso R. Overview of Helicobacter pylori Infection: clinical features, treatment, and nutritional aspects. Diseases. 2021;9(4):66.PubMedPubMedCentralCrossRef Öztekin M, Yılmaz B, Ağagündüz D, Capasso R. Overview of Helicobacter pylori Infection: clinical features, treatment, and nutritional aspects. Diseases. 2021;9(4):66.PubMedPubMedCentralCrossRef
7.
Zurück zum Zitat Shu L, Zheng P-F, Zhang X-Y, Feng Y-L: Dietary patterns and Helicobacter pylori infection in a group of Chinese adults ages between 45 and 59 years old: an observational study. Medicine 2019;98(2):1–8. Shu L, Zheng P-F, Zhang X-Y, Feng Y-L: Dietary patterns and Helicobacter pylori infection in a group of Chinese adults ages between 45 and 59 years old: an observational study. Medicine 2019;98(2):1–8.
8.
Zurück zum Zitat Xia Y, Meng G, Zhang Q, Liu L, Wu H, Shi H, Bao X, Su Q, Gu Y, Fang L. Dietary patterns are associated with Helicobacter pylori infection in Chinese adults: a cross-sectional study. Sci Rep. 2016;6(1):1–8. Xia Y, Meng G, Zhang Q, Liu L, Wu H, Shi H, Bao X, Su Q, Gu Y, Fang L. Dietary patterns are associated with Helicobacter pylori infection in Chinese adults: a cross-sectional study. Sci Rep. 2016;6(1):1–8.
9.
Zurück zum Zitat Johansen JS, Harris AK, Rychly DJ, Ergul A. Oxidative stress and the use of antioxidants in diabetes: linking basic science to clinical practice. Cardiovasc Diabetol. 2005;4(1):1–11.CrossRef Johansen JS, Harris AK, Rychly DJ, Ergul A. Oxidative stress and the use of antioxidants in diabetes: linking basic science to clinical practice. Cardiovasc Diabetol. 2005;4(1):1–11.CrossRef
10.
Zurück zum Zitat Yang-Ou YB, Hu Y, Zhu Y, Lu NH. The effect of antioxidants on Helicobacter pylori eradication: a systematic review with meta-analysis. Helicobacter. 2018;23(6): e12535.PubMedCrossRef Yang-Ou YB, Hu Y, Zhu Y, Lu NH. The effect of antioxidants on Helicobacter pylori eradication: a systematic review with meta-analysis. Helicobacter. 2018;23(6): e12535.PubMedCrossRef
11.
Zurück zum Zitat Salgueiro J, Zubillaga M, Goldman C, Barrado A, Martinez Sarrasague M, Leonardi N, Boccio J. is there a link between micronutrient malnutrition and Helicobacter pylori infection? Aliment Pharmacol Ther. 2004;20(10):1029–34.PubMedCrossRef Salgueiro J, Zubillaga M, Goldman C, Barrado A, Martinez Sarrasague M, Leonardi N, Boccio J. is there a link between micronutrient malnutrition and Helicobacter pylori infection? Aliment Pharmacol Ther. 2004;20(10):1029–34.PubMedCrossRef
12.
Zurück zum Zitat Solnick JV, Franceschi F, Roccarina D, Gasbarrini A. Extragastric manifestations of Helicobacter pylori infection–other Helicobacter species. Helicobacter. 2006;11:46–51.PubMedCrossRef Solnick JV, Franceschi F, Roccarina D, Gasbarrini A. Extragastric manifestations of Helicobacter pylori infection–other Helicobacter species. Helicobacter. 2006;11:46–51.PubMedCrossRef
13.
Zurück zum Zitat Capurso G, Ricci R, Panzuto F, Baccini F, Passi S, Di Giulio E, Fave GD, Annibale B. Intragastric ascorbic but not uric acid is depleted in relation with the increased pH in patients with atrophic body gastritis and H. pylori gastritis. Helicobacter. 2003;8(4):300–6.PubMedCrossRef Capurso G, Ricci R, Panzuto F, Baccini F, Passi S, Di Giulio E, Fave GD, Annibale B. Intragastric ascorbic but not uric acid is depleted in relation with the increased pH in patients with atrophic body gastritis and H. pylori gastritis. Helicobacter. 2003;8(4):300–6.PubMedCrossRef
14.
Zurück zum Zitat Vitale G, Barbaro F, Ianiro G, Cesario V, Gasbarrini G, Franceschi F, Gasbarrini A. Nutritional aspects of Helicobacter pylori infection. Minerva Gastroenterol Dietol. 2011;57(4):369–77.PubMed Vitale G, Barbaro F, Ianiro G, Cesario V, Gasbarrini G, Franceschi F, Gasbarrini A. Nutritional aspects of Helicobacter pylori infection. Minerva Gastroenterol Dietol. 2011;57(4):369–77.PubMed
15.
Zurück zum Zitat Wang X, Willén R, Wadström T. Astaxanthin-rich algal meal and vitamin C inhibit Helicobacter pylori infection in BALB/cA mice. Antimicrob Agents Chemother. 2000;44(9):2452–7.PubMedPubMedCentralCrossRef Wang X, Willén R, Wadström T. Astaxanthin-rich algal meal and vitamin C inhibit Helicobacter pylori infection in BALB/cA mice. Antimicrob Agents Chemother. 2000;44(9):2452–7.PubMedPubMedCentralCrossRef
16.
Zurück zum Zitat Sezikli M, Çetinkaya ZA, Güzelbulut F, Çimen B, Özcan Ö, Özkara S, Yeşil A, Gümrükçü G, İpçioğlu OM, Sezikli H. Effects of alpha tocopherol and ascorbic acid on Helicobacter pylori colonization and the severity of gastric inflammation. Helicobacter. 2012;17(2):127–32.PubMedCrossRef Sezikli M, Çetinkaya ZA, Güzelbulut F, Çimen B, Özcan Ö, Özkara S, Yeşil A, Gümrükçü G, İpçioğlu OM, Sezikli H. Effects of alpha tocopherol and ascorbic acid on Helicobacter pylori colonization and the severity of gastric inflammation. Helicobacter. 2012;17(2):127–32.PubMedCrossRef
17.
Zurück zum Zitat Rokkas T, Papatheodorou G, Karameris A, Mavrogeorgis A, Kalogeropoulos N, Giannikos N. Helicobacter pylori infection and gastric juice vitamin C levels. Dig Dis Sci. 1995;40(3):615–21.PubMedCrossRef Rokkas T, Papatheodorou G, Karameris A, Mavrogeorgis A, Kalogeropoulos N, Giannikos N. Helicobacter pylori infection and gastric juice vitamin C levels. Dig Dis Sci. 1995;40(3):615–21.PubMedCrossRef
18.
Zurück zum Zitat Woodward M, Tunstall-Pedoe H, McColl K. Helicobacter pylori infection reduces systemic availability of dietary vitamin C. Eur J Gastroenterol Hepatol. 2001;13(3):233–7.PubMedCrossRef Woodward M, Tunstall-Pedoe H, McColl K. Helicobacter pylori infection reduces systemic availability of dietary vitamin C. Eur J Gastroenterol Hepatol. 2001;13(3):233–7.PubMedCrossRef
19.
Zurück zum Zitat Rokkas T, Liatsos C, Petridou E, Papatheodorou G, Karameris A, Ladas S, Raptis S. Relationship of Helicobacter pylori CagA (+) status to gastric juice vitamin C levels. Eur J Clin Invest. 1999;29(1):56–62.PubMedCrossRef Rokkas T, Liatsos C, Petridou E, Papatheodorou G, Karameris A, Ladas S, Raptis S. Relationship of Helicobacter pylori CagA (+) status to gastric juice vitamin C levels. Eur J Clin Invest. 1999;29(1):56–62.PubMedCrossRef
20.
Zurück zum Zitat Sanderson MJ, White K, Drake IM, Schorah CJ. Vitamin E and carotenoids in gastric biopsies: the relation to plasma concentrations in patients with and without Helicobacter pylori gastritis. Am J Clin Nutr. 1997;65(1):101–6.PubMedCrossRef Sanderson MJ, White K, Drake IM, Schorah CJ. Vitamin E and carotenoids in gastric biopsies: the relation to plasma concentrations in patients with and without Helicobacter pylori gastritis. Am J Clin Nutr. 1997;65(1):101–6.PubMedCrossRef
21.
Zurück zum Zitat Sugimoto N, Yoshida N, Nakamura Y, Ichikawa H, Naito Y, Okanoue T, Yoshikawa T. Influence of vitamin E on gastric mucosal injury induced by Helicobacter pylori infection. BioFactors. 2006;28(1):9–19.PubMedCrossRef Sugimoto N, Yoshida N, Nakamura Y, Ichikawa H, Naito Y, Okanoue T, Yoshikawa T. Influence of vitamin E on gastric mucosal injury induced by Helicobacter pylori infection. BioFactors. 2006;28(1):9–19.PubMedCrossRef
22.
Zurück zum Zitat Fung TT, Hu FB, Pereira MA, Liu S, Stampfer MJ, Colditz GA, Willett WC. Whole-grain intake and the risk of type 2 diabetes: a prospective study in men. Am J Clin Nutr. 2002;76(3):535–40.PubMedCrossRef Fung TT, Hu FB, Pereira MA, Liu S, Stampfer MJ, Colditz GA, Willett WC. Whole-grain intake and the risk of type 2 diabetes: a prospective study in men. Am J Clin Nutr. 2002;76(3):535–40.PubMedCrossRef
23.
Zurück zum Zitat Ahmad S, Harris T, Limb E, Kerry S, Victor C, Ekelund U, Iliffe S, Whincup P, Beighton C, Ussher M. Evaluation of reliability and validity of the General Practice Physical Activity Questionnaire (GPPAQ) in 60–74 year old primary care patients. BMC Fam Pract. 2015;16(1):1–9.CrossRef Ahmad S, Harris T, Limb E, Kerry S, Victor C, Ekelund U, Iliffe S, Whincup P, Beighton C, Ussher M. Evaluation of reliability and validity of the General Practice Physical Activity Questionnaire (GPPAQ) in 60–74 year old primary care patients. BMC Fam Pract. 2015;16(1):1–9.CrossRef
24.
Zurück zum Zitat Esfahani FH, Asghari G, Mirmiran P, Azizi F. Reproducibility and relative validity of food group intake in a food frequency questionnaire developed for the Tehran Lipid and Glucose Study. J Epidemiol. 2010;20(2):150–8.PubMedCrossRef Esfahani FH, Asghari G, Mirmiran P, Azizi F. Reproducibility and relative validity of food group intake in a food frequency questionnaire developed for the Tehran Lipid and Glucose Study. J Epidemiol. 2010;20(2):150–8.PubMedCrossRef
25.
Zurück zum Zitat LuuHung N, Are dietary antioxidant intake indices correlated to oxidative stress and inflammatory marker levels?. In.: Mary Ann Liebert, Inc. 140 Huguenot Street, 3rd Floor New Rochelle, NY 10801 USA; 2015. LuuHung N, Are dietary antioxidant intake indices correlated to oxidative stress and inflammatory marker levels?. In.: Mary Ann Liebert, Inc. 140 Huguenot Street, 3rd Floor New Rochelle, NY 10801 USA; 2015.
26.
Zurück zum Zitat Abdollahpour I, Nedjat S, Salimi Y, Mansournia MA, Vahid F, Weinstock-Guttman B. The role of dietary antioxidant index and index of nutritional quality in MS onset: finding from an Iranian population-based incident case–control study. Nutr Neurosci. 2020;25(2):1–8. Abdollahpour I, Nedjat S, Salimi Y, Mansournia MA, Vahid F, Weinstock-Guttman B. The role of dietary antioxidant index and index of nutritional quality in MS onset: finding from an Iranian population-based incident case–control study. Nutr Neurosci. 2020;25(2):1–8.
27.
Zurück zum Zitat Benzie IF, Strain JJ. The ferric reducing ability of plasma (FRAP) as a measure of “antioxidant power”: the FRAP assay. Anal Biochem. 1996;239(1):70–6.PubMedCrossRef Benzie IF, Strain JJ. The ferric reducing ability of plasma (FRAP) as a measure of “antioxidant power”: the FRAP assay. Anal Biochem. 1996;239(1):70–6.PubMedCrossRef
29.
Zurück zum Zitat Vahid F, Rahmani D, Davoodi SH. Validation of Dietary Antioxidant Index (DAI) and investigating the relationship between DAI and the odds of gastric cancer. Nutr Metab. 2020;17(1):102.CrossRef Vahid F, Rahmani D, Davoodi SH. Validation of Dietary Antioxidant Index (DAI) and investigating the relationship between DAI and the odds of gastric cancer. Nutr Metab. 2020;17(1):102.CrossRef
31.
Zurück zum Zitat Vahid F, Rahmani D, Hekmatdoost A. The association between dietary antioxidant index (DAI) and nonalcoholic fatty liver disease (NAFLD) onset; new findings from an incident case-control study. Clinical nutrition ESPEN. 2021;41:360–4.PubMedCrossRef Vahid F, Rahmani D, Hekmatdoost A. The association between dietary antioxidant index (DAI) and nonalcoholic fatty liver disease (NAFLD) onset; new findings from an incident case-control study. Clinical nutrition ESPEN. 2021;41:360–4.PubMedCrossRef
32.
Zurück zum Zitat Vahid F, Rahmani D, Davoodi SH. The correlation between serum inflammatory, antioxidant, glucose handling biomarkers, and Dietary Antioxidant Index (DAI) and the role of DAI in obesity/overweight causation: population-based case-control study. Int J Obes. 2021;45(12):2591–9.CrossRef Vahid F, Rahmani D, Davoodi SH. The correlation between serum inflammatory, antioxidant, glucose handling biomarkers, and Dietary Antioxidant Index (DAI) and the role of DAI in obesity/overweight causation: population-based case-control study. Int J Obes. 2021;45(12):2591–9.CrossRef
34.
Zurück zum Zitat Jarosz M, Rychlik E, Siuba M, Respondek W, Ryzko-Skiba M, Sajór I, Gugała S, Błazejczyk T, Ciok J. Dietary and socio-economic factors in relation to Helicobacter pylori re-infection. World J Gastroenterol. 2009;15(9):1119–25.PubMedPubMedCentralCrossRef Jarosz M, Rychlik E, Siuba M, Respondek W, Ryzko-Skiba M, Sajór I, Gugała S, Błazejczyk T, Ciok J. Dietary and socio-economic factors in relation to Helicobacter pylori re-infection. World J Gastroenterol. 2009;15(9):1119–25.PubMedPubMedCentralCrossRef
35.
Zurück zum Zitat Annibale B, Capurso G, Lahner E, Passi S, Ricci R, Maggio F, Delle Fave G. Concomitant alterations in intragastric pH and ascorbic acid concentration in patients with Helicobacter pylori gastritis and associated iron deficiency anaemia. Gut. 2003;52(4):496–501.PubMedPubMedCentralCrossRef Annibale B, Capurso G, Lahner E, Passi S, Ricci R, Maggio F, Delle Fave G. Concomitant alterations in intragastric pH and ascorbic acid concentration in patients with Helicobacter pylori gastritis and associated iron deficiency anaemia. Gut. 2003;52(4):496–501.PubMedPubMedCentralCrossRef
36.
Zurück zum Zitat Kashimura H, Suzuki K, Hassan M, Ikezawa K, Sawahata T, Watanabe T, Nakahara A, Mutoh H, Tanaka N. Polaprezinc, a mucosal protective agent, in combination with lansoprazole, amoxycillin and clarithromycin increases the cure rate of Helicobacter pylori infection. Aliment Pharmacol Ther. 1999;13(4):483–7.PubMedCrossRef Kashimura H, Suzuki K, Hassan M, Ikezawa K, Sawahata T, Watanabe T, Nakahara A, Mutoh H, Tanaka N. Polaprezinc, a mucosal protective agent, in combination with lansoprazole, amoxycillin and clarithromycin increases the cure rate of Helicobacter pylori infection. Aliment Pharmacol Ther. 1999;13(4):483–7.PubMedCrossRef
37.
Zurück zum Zitat Sempértegui F, Diaz M, Mejia R, Rodríguez-Mora OG, Rentería E, Guarderas C, Estrella B, Recalde R, Hamer DH, Reeves PG. Low Concentrations of zinc in gastric Mucosa are associated with increased severity of helicobacter pylori-induced inflammation. Helicobacter. 2007;12(1):43–8.PubMedCrossRef Sempértegui F, Diaz M, Mejia R, Rodríguez-Mora OG, Rentería E, Guarderas C, Estrella B, Recalde R, Hamer DH, Reeves PG. Low Concentrations of zinc in gastric Mucosa are associated with increased severity of helicobacter pylori-induced inflammation. Helicobacter. 2007;12(1):43–8.PubMedCrossRef
38.
Zurück zum Zitat Zhang HM, Wakisaka N, Maeda O, Yamamoto T. Vitamin C inhibits the growth of a bacterial risk factor for gastric carcinoma: Helicobacter pylori. Cancer: Interdisc Int J Am Cancer Soc. 1997;80(10):1897–903.CrossRef Zhang HM, Wakisaka N, Maeda O, Yamamoto T. Vitamin C inhibits the growth of a bacterial risk factor for gastric carcinoma: Helicobacter pylori. Cancer: Interdisc Int J Am Cancer Soc. 1997;80(10):1897–903.CrossRef
39.
Zurück zum Zitat Sjunnesson H, Sturegård E, Willén R, Wadström T. High intake of selenium, -carotene, and vitamins A, C, and E reduces growth of Helicobacter pylori in the Guinea Pig. Comp Med. 2001;51(5):418–23.PubMed Sjunnesson H, Sturegård E, Willén R, Wadström T. High intake of selenium, -carotene, and vitamins A, C, and E reduces growth of Helicobacter pylori in the Guinea Pig. Comp Med. 2001;51(5):418–23.PubMed
40.
Zurück zum Zitat Ishihara R, Iishi H, Sakai N, Yano H, Uedo N, Narahara H, Iseki K, Mikuni T, Ishiguro S, Tatsuta M. Polaprezinc attenuates Helicobacter pylori-associated gastritis in Mongolian gerbils. Helicobacter. 2002;7(6):384–9.PubMedCrossRef Ishihara R, Iishi H, Sakai N, Yano H, Uedo N, Narahara H, Iseki K, Mikuni T, Ishiguro S, Tatsuta M. Polaprezinc attenuates Helicobacter pylori-associated gastritis in Mongolian gerbils. Helicobacter. 2002;7(6):384–9.PubMedCrossRef
41.
Zurück zum Zitat Suzuki H, Mori M, Seto K, Miyazawa M, Kai A, Suematsu M, Yoneta T, Miura S, Ishii H. Polaprezinc attenuates the Helicobacter pylori-induced gastric mucosal leucocyte activation in Mongolian gerbils—a study using intravital videomicroscopy. Aliment Pharmacol Ther. 2001;15(5):715–25.PubMedCrossRef Suzuki H, Mori M, Seto K, Miyazawa M, Kai A, Suematsu M, Yoneta T, Miura S, Ishii H. Polaprezinc attenuates the Helicobacter pylori-induced gastric mucosal leucocyte activation in Mongolian gerbils—a study using intravital videomicroscopy. Aliment Pharmacol Ther. 2001;15(5):715–25.PubMedCrossRef
42.
Zurück zum Zitat Li G, Li L, Yu C, Chen L. Effect of vitamins C and E supplementation on Helicobacter pylori eradication: a meta-analysis. Br J Nutr. 2011;106(11):1632–7.PubMedCrossRef Li G, Li L, Yu C, Chen L. Effect of vitamins C and E supplementation on Helicobacter pylori eradication: a meta-analysis. Br J Nutr. 2011;106(11):1632–7.PubMedCrossRef
43.
Zurück zum Zitat Ochoa EYC, Moreno COQ, Fandiño YRM, Fonseca SCS, Motta HFC, Guerra SAG. Assessment of the use of vitamin C and E supplements concomitantly to antibiotic treatment against Helicobacter pylori: a systematic review and meta-analysis. Med Clínica (English Edition). 2018;151(2):45–52.CrossRef Ochoa EYC, Moreno COQ, Fandiño YRM, Fonseca SCS, Motta HFC, Guerra SAG. Assessment of the use of vitamin C and E supplements concomitantly to antibiotic treatment against Helicobacter pylori: a systematic review and meta-analysis. Med Clínica (English Edition). 2018;151(2):45–52.CrossRef
45.
Zurück zum Zitat Woodside JV, McCall D, McGartland C, Young IS. Micronutrients: dietary intake v. supplement use. Proc Nutr Soc. 2005;64(4):543–53.PubMedCrossRef Woodside JV, McCall D, McGartland C, Young IS. Micronutrients: dietary intake v. supplement use. Proc Nutr Soc. 2005;64(4):543–53.PubMedCrossRef
46.
Zurück zum Zitat Pal J, Sanal MG, Gopal GJ. Vitamin-C as anti-Helicobacter pylori agent: more prophylactic than curative-Critical review. Indian J Pharmacol. 2011;43(6):624.PubMedPubMedCentral Pal J, Sanal MG, Gopal GJ. Vitamin-C as anti-Helicobacter pylori agent: more prophylactic than curative-Critical review. Indian J Pharmacol. 2011;43(6):624.PubMedPubMedCentral
47.
Zurück zum Zitat Nilius M, Bode G, Lehnhardt G, Malfertheiner P. In vitro inhibition of Helicobacter pylori urease: biochemical and ultrastructural analysis. Eur J Clin Invest. 1991;21(5):551–7.PubMedCrossRef Nilius M, Bode G, Lehnhardt G, Malfertheiner P. In vitro inhibition of Helicobacter pylori urease: biochemical and ultrastructural analysis. Eur J Clin Invest. 1991;21(5):551–7.PubMedCrossRef
48.
Zurück zum Zitat Jarosz M, Dzieniszewski J, Dabrowska-Ufniarz E, Wartanowicz M, Ziemlanski S, Reed P. Effects of high dose vitamin C treatment on Helicobacter pylori infection and total vitamin C concentration in gastric juice. Eur J Cancer Prev. 1998;7(6):449–54.CrossRef Jarosz M, Dzieniszewski J, Dabrowska-Ufniarz E, Wartanowicz M, Ziemlanski S, Reed P. Effects of high dose vitamin C treatment on Helicobacter pylori infection and total vitamin C concentration in gastric juice. Eur J Cancer Prev. 1998;7(6):449–54.CrossRef
49.
Zurück zum Zitat Phull PS, Green CJ, Jacyna MR. A radical view of the stomach: the role of oxygen-derived free radicals and anti-oxidants in gastroduodenal disease. Eur J Gastroenterol Hepatol. 1995;7(3):265–74.PubMed Phull PS, Green CJ, Jacyna MR. A radical view of the stomach: the role of oxygen-derived free radicals and anti-oxidants in gastroduodenal disease. Eur J Gastroenterol Hepatol. 1995;7(3):265–74.PubMed
Metadaten
Titel
Association between dietary antioxidant index and risk of Helicobacter pylori infection among adults: a case–control study
verfasst von
Zohreh Ebrahimi
Mohsen Masoodi
Zahra Aslani
Sina Naghshi
Masoumeh Khalighi Sikaroudi
Farzad Shidfar
Publikationsdatum
01.12.2022
Verlag
BioMed Central
Erschienen in
BMC Gastroenterology / Ausgabe 1/2022
Elektronische ISSN: 1471-230X
DOI
https://doi.org/10.1186/s12876-022-02488-3

Weitere Artikel der Ausgabe 1/2022

BMC Gastroenterology 1/2022 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.